medication adherence

Sempre Health, a San Francisco-based company that uses monetary incentives and pricing to encourage healthy behaviors, announced today that it has obtained $8 million in Series A financing.

A study recently published in Heart found that coronary heart disease (CHD) patients assigned a smartphone app for medication reminders demonstrated greater adherence than those who did not.

Medication management and adherence app maker Medisafe has announced a partnership with Boehringer Ingelheim following a successful pilot.

Yesterday’s announcement that Apple would open the API for Health Records in iOS 12 will likely spawn a whole host of integrations with digital health companies in the coming months.

Replacing the frequent home visits often necessary for tuberculosis treatment with video visits facilitated by an app appears to be a cost-effective, well-received means of ensuring adherence throughout therapy, according to a recently published pilot study.

Following a successful nine-month pilot, Boehringer Ingelheim and HealthPrize Technologies announced that the digital adherence support program RespiPoints will be expanded to any patient who is taking certain Boehringer Ingelheim medications, including some available in the Respimat inhaler.

Cambridge, Massachusetts-based Common Sensing, which specializes in connected containers for injectable medications, has raised $6.

Medication management app maker Medisafe has a guiding principle when it comes to the difficult task of improving medication adherence: One size does not fit all.

A new large-scale study shows that interactive, tailored text messages can improve medication adherence by 14 percent.

Mount Sinai Health System is trying a new way to get high-risk patients to take their medications: financial incentives.